Topic tracked by 311 Institute
The future of GlaxoSmithKline
- 3articles
- 2019first covered
- 19 Feb 2022latest update
What is GlaxoSmithKline?
What is GlaxoSmithKline doing to bring the future to life?
Bringing the future to life
How GlaxoSmithKline is shaping what comes next
Latest developments
What GlaxoSmithKline did next
Coverage by year
Private briefing
What does the future of GlaxoSmithKline mean for you?
Matthew Griffin and 311 Institute brief boards and leadership teams on what GlaxoSmithKline is doing next, and what it means for your organisation.
Every article
All 3 articles on GlaxoSmithKline
- The WHO endorses the use of the world’s first Malaria vaccineBiotech and enhanced humans
- This new chemical programming language could revolutionise digital chemistryComputing
- An AI designed 30,000 drugs in 21 days and came up with winnersAI and intelligence
Connected
Also in the GlaxoSmithKline story
Answers
FAQ
How many articles has 311 Institute published about GlaxoSmithKline?
311 Institute has published 3 articles about GlaxoSmithKline since 2019, most recently on 19 February 2022.
Can 311 Institute brief my board on the future of GlaxoSmithKline?
Yes. Matthew Griffin and 311 Institute run private briefings, workshops and keynotes on what GlaxoSmithKline is doing next and what it means for your organisation. Use the briefing form on this page and Matthew will reply quickly.
Follow the future of GlaxoSmithKline
Get an alert when 311 Institute publishes something new on GlaxoSmithKline. Short, useful, free.